Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
06/16/2011 | US20110142968 Nutritional supplement |
06/16/2011 | US20110142964 Increasing athletic performance in humans with ruta chalepensis extract |
06/16/2011 | US20110142948 Nanoparticle Carrier Systems based on Human Serum Albumin for Photodynamic Therapy |
06/16/2011 | US20110142943 Tamper-resistant pharmaceutical compositions of opiods and other drugs |
06/16/2011 | US20110142932 Pharmaceutical Tablets Comprising a Plurality of Segments |
06/16/2011 | US20110142920 Treatment of length dependent neuropathy |
06/16/2011 | US20110142915 Compositions and methods for inhibition of vegf |
06/16/2011 | US20110142914 Inhalable compositions having enhanced bioavailability |
06/16/2011 | US20110142903 Controlled-release, intra-articular therapeutic agent delivery compound, and a methodology for the controlled-release of an intra-articular therapeutic agent delivery compound |
06/16/2011 | US20110142895 Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure |
06/16/2011 | US20110142886 Pegylated polyplexes for polynucleotide delivery |
06/16/2011 | US20110142884 Materials and Methods for Making Improved Micelle Compositions |
06/16/2011 | US20110142879 Infectious clones |
06/16/2011 | US20110142868 Peptidylarginine Deiminase (PAD) Inhibitors |
06/16/2011 | US20110142867 Immunotherapeutic methods and systems |
06/16/2011 | US20110142856 Compound containing basic group and use thereof |
06/16/2011 | US20110142853 Engineered Anti-IL-23p19 Antibodies |
06/16/2011 | US20110142851 IL6 Immunotherapeutics |
06/16/2011 | US20110142850 Method of treating cd40-mediated diseases |
06/16/2011 | US20110142836 B-cell depleting agents for the treatment of chronic fatigue syndrome |
06/16/2011 | US20110142835 Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis |
06/16/2011 | US20110142833 Methods for treating and preventing fibrosis |
06/16/2011 | US20110142831 Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease |
06/16/2011 | US20110142821 Roles for dual endothelin-1/angiotensin ii receptor (dear) in hypertension and angiogenesis |
06/16/2011 | US20110142807 Mesenchymal Stem Cells and Uses Therefor |
06/16/2011 | US20110142787 Polymerized cyclic nitroxide radical compound and use thereof |
06/16/2011 | US20110142777 Use of indole compounds as a cosmetic |
06/16/2011 | US20110142769 Low toxicity topical active agent delivery system |
06/16/2011 | US20110142761 Il-1 binding proteins |
06/16/2011 | US20110142757 Novel compounds and their uses in diagnosis |
06/16/2011 | US20110138888 Treatment of obesity |
06/16/2011 | CA2784005A1 Nanoparticle carrier systems based on poly(dl-lactic-co-glycolic acid) (plga) for photodynamic therapy (pdt) |
06/16/2011 | CA2783731A1 Aminoacyl trna synthetases for modulating inflammation |
06/16/2011 | CA2781233A1 Novel therapeutic methods for treating inflammation and immune system disorders |
06/16/2011 | CA2781218A1 Heterocyclic sulfonamide derivatives |
06/15/2011 | EP2333052A1 Desaturase genes and uses thereof |
06/15/2011 | EP2332978A1 Novel polypeptides involved in immune response |
06/15/2011 | EP2332976A1 Novel polypeptides involved in immune response |
06/15/2011 | EP2332962A1 Cyclopenta[g]quinazoline compounds for use in the treatment of inflammatory or allergic conditions |
06/15/2011 | EP2332933A1 Epithelial sodium channel (ENaC) inhibitors |
06/15/2011 | EP2332932A1 Novel crystal forms of 4-(2-aminopyridin-4-yl)-3-(4 fluoro- phenyl)-1-(1,4,5,6-tetrahydro-6-oxopyridazin-3-yl)-1h-pyra-zole methanesulfonate and process for production of same |
06/15/2011 | EP2332930A1 Salts of duloxetine and NSAIDs for the treatment of pain |
06/15/2011 | EP2332924A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
06/15/2011 | EP2332922A1 N-substituted azoles and their use as MEK-1 and/or ERK-2 modulators |
06/15/2011 | EP2332579A2 Antibodies that bind human interleukin-18 and methods of making and using |
06/15/2011 | EP2332578A1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
06/15/2011 | EP2332563A2 Use of BAFF to treat sepsis |
06/15/2011 | EP2332559A1 Peptides for the treatment of pain |
06/15/2011 | EP2332550A1 Tetracyclines for the treatment of neurodegenerative diseases |
06/15/2011 | EP2332549A1 Novel tetracyclines and their use in medicine |
06/15/2011 | EP2332548A1 Tetracyclines for the treatment of stroke |
06/15/2011 | EP2332547A1 Tetracyclines for the treatment of inflammatory bowel disease |
06/15/2011 | EP2332546A1 Tetracyclines for the treatment of stroke |
06/15/2011 | EP2332541A1 Use of thioxanthine derivatives as MPO inhibitors |
06/15/2011 | EP2332533A1 Cannabinoid-containing plant extracts as neuroprotective agents |
06/15/2011 | EP2332531A1 Apo2 ligand/TRAIL formulations |
06/15/2011 | EP2332529A1 Substituted aromatic diamines as ligands of vesicular glutamate transporter 1 and 2 (vGLUT1 and vGLUT2) |
06/15/2011 | EP2332528A1 Substituted aromatic dicarbonic acid amides as medicaments |
06/15/2011 | EP2332523A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
06/15/2011 | EP2331541A1 Indolizine inhibitors of leukotriene production |
06/15/2011 | EP2331525A2 Halofuginone analogs for inhibition of trna synthetases and uses thereof |
06/15/2011 | EP2331518A1 New bradykinin b1 antagonists |
06/15/2011 | EP2331516A1 Imine derivatives as cannabinoid receptor ligands |
06/15/2011 | EP2331515A1 Insceticidal compounds |
06/15/2011 | EP2331498A2 Cold menthol receptor antagonists |
06/15/2011 | EP2331103A1 Nuclear factor kappa b pathway inhibitor composition and use of same |
06/15/2011 | EP2331100A2 Methods and kits for treating cluster headache disorders |
06/15/2011 | EP2104535B9 Compounds and compositions as channel activating protease inhibitors |
06/15/2011 | EP1937650B1 Heterocyclic compounds |
06/15/2011 | EP1827413B1 Use of cyclodextrin complexes containing lipoic acid |
06/15/2011 | EP1349558B1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
06/15/2011 | EP1131080B2 Selection and uses of lactic acid bacteria strains modulating non-specific immunity |
06/15/2011 | EP1052254B1 Nitrogenous heterocyclic derivatives and medicine thereof |
06/15/2011 | EP0939804B2 NEUTROKINE alpha |
06/15/2011 | CN1939380B Heat-clearing analgesic medicinal composition with anti-infective and antiviral functions |
06/15/2011 | CN102099471A Aptamer against il-17 and use thereof |
06/15/2011 | CN102099467A SiRNA of human osteopontin |
06/15/2011 | CN102099356A Heterocyclic derivatives as modulators of ion channels |
06/15/2011 | CN102099355A Phenyl and benzodioxinyl substituted indazoles derivatives |
06/15/2011 | CN102099352A STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient |
06/15/2011 | CN102099336A Novel phenylamino isonicotinamide compounds |
06/15/2011 | CN102093944A Chinese medicinal wine |
06/15/2011 | CN102093380A Cyclic icaritin aglycon as well as preparation method and application of cyclic icaritin aglycon |
06/15/2011 | CN102093373A Compounds formed by structural modifiecation of sinomenine and preparation method thereof |
06/15/2011 | CN102093364A 2,4-diamido-6,7-dihydro-5H-pyrrolo [2,3] pyrimidine derivative as focal adhesion kinase/pyruvate kinase 2 (FAK/Pyk2) inhibitor |
06/15/2011 | CN102093363A Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
06/15/2011 | CN102093353A 7-substituted aza-indazoles, compositions containing same, production method and use thereof |
06/15/2011 | CN102091316A Traditional Chinese medicine for treating rheumatoid arthritis |
06/15/2011 | CN102091311A Traditional Chinese medicinal composition for treating rheumatoid arthritis and preparation method thereof |
06/15/2011 | CN102091307A Traditional Chinese medicine composition for treating cold |
06/15/2011 | CN102091297A Quality control method for liver health care medicine |
06/15/2011 | CN102091289A Traditional Chinese medicine preparation with functions of clearing heat and cooling blood, promoting blood circulation to remove blood stasis and eliminating swelling and alleviating pain |
06/15/2011 | CN102091286A Traditional Chinese patent medicine for abating fever |
06/15/2011 | CN102091285A Medicinal preparation for clearing heat and restoring consciousness, preparation method thereof and application thereof |
06/15/2011 | CN102091274A Medicament for treating abdominal pain and diarrhea caused by infantile umbilical hernia and preparation method thereof |
06/15/2011 | CN102091272A Black plaster product for bone fracture and preparation method thereof |
06/15/2011 | CN102091254A Traditional Chinese medicine composition for relieving swelling after cosmetic surgery and preparation method thereof |
06/15/2011 | CN102091235A Medicament for treating vertebara swell and production method thereof |
06/15/2011 | CN102091208A Nanometer selenium-germanium snake-bee element traditional Chinese medicinal far-infrared negative ion anti-electromagnetic wave body-strengthening dissolved medicine |
06/15/2011 | CN102091205A Liniment containing fortune's drynaria rhizome, safflower and frankincense and preparation method thereof |